Detalhe da pesquisa
1.
Switching from combination therapy with entecavir hydrate plus tenofovir alafenamide fumarate to tenofovir alafenamide fumarate monotherapy in patients with chronic hepatitis B based on nucleotide sequences of hepatitis B virus pregenome RNA.
Hepatol Res
; 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38517681
2.
Significance of portal venous blood flow as a factor to determine liver function in patients with decompensated cirrhosis due to hepatitis C virus infection following achievement of sustained viral response by sofosbuvir plus velpatasvir.
Hepatol Res
; 53(9): 815-828, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243512
3.
Evaluation of an immunochromatography-based rapid antigen test, Inspecter Kowa® SARS-CoV-2, using saliva specimens for the detection of SARS-CoV-2.
J Infect Chemother
; 29(6): 586-591, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36849098
4.
Significance of furosemide in patients with cirrhosis treated with or without zinc acetate hydrate supplementation.
Hepatol Res
; 52(5): 449-461, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35113468
5.
Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate.
J Med Virol
; 92(3): 329-338, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31777965
6.
Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis.
Hepatol Res
; 50(12): 1355-1364, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32886950
7.
Furosemide as a factor to deteriorate therapeutic efficacy of rifaximin in patients with decompensated cirrhosis.
Hepatol Res
; 50(11): 1264-1274, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32833292
8.
Involvement of portosystemic shunts in impaired improvement of liver function after direct-acting antiviral therapies in cirrhotic patients with hepatitis C virus.
Hepatol Res
; 50(4): 512-523, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31837277
9.
Deteriorated outcome of recent patients with acute liver failure and late-onset hepatic failure caused by infection with hepatitis A virus: A subanalysis of patients seen between 1998 and 2015 and enrolled in nationwide surveys in Japan.
Hepatol Res
; 49(8): 844-852, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30957325
10.
A case of genotype-3b hepatitis C virus in which the whole genome was successfully analyzed using third-generation nanopore sequencing.
Hepatol Res
; 49(9): 1083-1087, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30924272
11.
Chronic hepatitis caused by hepatitis C virus showing a discrepancy between serogroup and genotype because of intergenotypic 2b/1b recombination: A pitfall in antiviral therapy with direct-acting antivirals.
Hepatol Res
; 48(3): E372-E378, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28872737
12.
A multicenter pilot survey to clarify the clinical features of patients with acute-on-chronic liver failure in Japan.
Hepatol Res
; 48(4): 303-312, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29341357
13.
Retreatment with sofosbuvir/ledipasvir with or without lead-in interferon-ß injections in patients infected with genotype 1b hepatitis C virus after unsuccessful daclatasvir/asunaprevir therapy.
Hepatol Res
; 48(4): 233-243, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28884930
14.
"Reversi-type virologic failure" involved in the development of non-structural protein 5A resistance-associated variants (RAVs) in patients with genotype 1b hepatitis C carrying no signature RAVs at baseline.
Hepatol Res
; 47(13): 1397-1407, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28239934
15.
Development of rare resistance-associated variants that are extremely tolerant against NS5A inhibitors during daclatasvir/asunaprevir therapy by a two-hit mechanism.
Hepatol Res
; 46(12): 1234-1246, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26878268
16.
Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate.
J Med Virol
; 92(8): 1370, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32677098
17.
Novel hepatitis B virus strain developing due to recombination between genotypes H and B strains isolated from a Japanese patient.
Hepatol Res
; 44(11): 1130-1141, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24020990
18.
Usefulness of atezolizumab plus bevacizumab as second-line therapy for patients with unresectable hepatocellular carcinoma.
PLoS One
; 19(4): e0298770, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687817
19.
Long-term effects of ipragliflozin and pioglitazone on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow-up of a randomized, 24 week, active-controlled trial: Effect of ipragliflozin in MASLD.
J Diabetes Investig
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38775319